Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world Study of Butylphthalide for Ischemic Stroke
NCT05068349Phase 4Recruiting
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- May 2022
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of butylphthalide in ischemic stroke, sponsored by Shandong Provincial Qianfoshan Hospital. Started May 2022; status: recruiting.
02
Drugs
butylphthalide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05068349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05068349.